Paper II
2024 December (Supplementary) (2019 Scheme) · 100 marks · 180 min

Question

A: Specific antivirals are available to treat Japanese Encephalitis. R: Japanese Encephalitis is the most common cause of vaccine preventable encephalitis in Asia.

  • a) Both A and R are true and R is the correct explanation of A
  • c) A is true but R is false
  • b) Both A and R are true and R is not the correct explanation of A
  • d) A is false but R is true
Qxvii1 marksMCQs

Answer

- [x] d) A is false but R is true

Assertion is false: no specific antiviral treatment is currently available for Japanese Encephalitis — management is purely supportive (there is no proven, licensed antiviral agent specifically effective against JE virus). Reason is true: Japanese Encephalitis is indeed the most common cause of vaccine-preventable viral encephalitis in Asia — safe and effective JE vaccines exist and are used in national immunization programmes across endemic Asian countries, making prevention (rather than antiviral treatment) the primary strategy against this disease.

Other Years Asked


Revise MBBS
Preview